Bioisosterism between Sulfonyl Group and Phosphoryl Group-The Synthesis of New ALS Inhibitors N-(Arylamino Hydroxyl Phosphoryl)-N'-(4,6-Dimethoxypyrimidine-2-yl)ureas

Sulfonylureaherbicidesisanewclassofherbicidesdiscoveredinthemid-l97O's',whosemodeofactionhasbeenestablishedastheinhibitionofacetolactatesynthase(ALS,alsoreferredasacetohydroxyacidsynthase)'-Muchattentionhasbeenfocussedonthiskindofcompound,sincetheyhaveunprecedenteduserates,ahighdegreeofselectivity,andexcellentenvironmentalsafety'.NumerousmodificationsofthestrUctureofthisclassofherbicideshavebeenreported'.Wehavetakenattentiontothesimi1alltybetweenthesulfonylgroup(-SO2-)andphosphoryIgroup[-P…     

The synthesis of novel acetolactate synthase inhibitors,N‐(asymmetrically disubstituted phosphoryl)‐N′‐(4,6‐dimethoxypyrimidin‐2‐yl) ureas

In view of the isosterism of the sulfonyl group(‐SO₂‐) and the phosphoryl group, two new types of compounds N‐(N‐aryl‐O‐alkyl phosphoryl)‐N′‐(4,6‐dimethoxypyrimidin‐2‐yl) ureas (2) and N‐(N‐aryl‐N‐alkylphosphoryl)‐N′‐(4,6‐dimethoxypyrimidin‐2‐yl) ureas (3) were designed and synthesized by treating N‐(arylaminochlorophosphoryl)‐N′‐(4,6‐dimethoxypy‐rimidinyl‐2‐) ureas (4) with alcohols or amines. Compounds 4 were obtained by treating dichloro‐phosphoryl isocyanate with 4,6‐dimethoxy‐2‐amino‐pyrimidine and then with aromatic amines. The enzyme tests in vitro indicated that compounds 2 and 3 were two novel classes of acetolactate synthase (ALS) inhibitors and also showed that phosphoryl groups[‐P(O)(OR)‐, R=alkyl] and [‐P(O)(NHR), R=alkyl] were likely to be good bioisosteres of the sulfonyl group (‐SO₂‐) in the sulfonylureas. © 1999 John Wiley & Sons, Inc. Heteroatom Chem 10:237–241, 1999     

Ruthenium(II) and ruthenium(IV) complexes containing kappa1-P-, kappa2-P,O-, and kappa3-P,N,O-iminophosphorane-phosphine ligands Ph2PCH2P[=NP(=O)(OR)2]Ph2 (R = Et,Ph): synthesis,reactivity, theoretical studies,and catalytic activity in transfer hydrogenation of cyclohexanone

[(Ru(eta(6)-p-cymene)(mu-Cl)Cl)(2)] and [(Ru(eta(3):eta(3)-C(10)H(16))(mu-Cl)Cl)(2)] react with Ph(2)PCH(2)P[=NP(=O)(OR)(2)]Ph(2) (R = Et (1a), Ph (1b)) affording complexes [Ru(eta(6)-p-cymene)Cl(2)(kappa(1)-P-Ph(2)PCH(2)P[=NP(=O)(OR)(2)]Ph(2))] (R = Et (2a), Ph (2b)) and [Ru(eta(3):eta(3)-C(10)H(16))Cl(2)(kappa(1)-P-Ph(2)PCH(2)P[=NP(=O)(OR)(2)]Ph(2))] (R = Et (6a), Ph (6b)). While treatment of 2a with 1 equiv of AgSbF(6) yields a mixture of [Ru(eta(6)-p-cymene)Cl(kappa(2)-P,O-Ph(2)PCH(2)P[=NP(=O)(OEt)(2)]Ph(2))][SbF(6)] (3a) and [Ru(eta(6)-p-cymene)Cl(kappa(2)-P,N-Ph(2)PCH(2)P[=NP(=O)(OEt)(2)]Ph(2))][SbF(6)] (4a), [Ru(eta(6)-p-cymene)Cl(kappa(2)-P,O-Ph(2)PCH(2)P[=NP(=O)(OPh)(2)]Ph(2))][SbF(6)] (3b) and [Ru(eta(3):eta(3)-C(10)H(16))Cl(kappa(2)-P,O-Ph(2)PCH(2)P[=NP(=O)(OR)(2)]Ph(2))][SbF(6)] (R = Et (7a), Ph (7b)) are selectively formed from 2b and 6a,b. Complexes [Ru(eta(6)-p-cymene)(kappa(3)-P,N,O-Ph(2)PCH(2)P[=NP(=O)(OR)(2)]Ph(2))][SbF(6)](2) (R = Et (5a), Ph (5b)) and [Ru(eta(3):eta(3)-C(10)H(16))(kappa(3)-P,N,O-Ph(2)PCH(2)P[=NP(=O)(OR)(2)]Ph(2))][SbF(6)](2) (R = Et (8a), Ph (8b)) have been prepared using 2 equiv of AgSbF(6). The reactivity of 3-5a,b has been explored allowing the synthesis of [Ru(eta(6)-p-cymene)X(2)(kappa(1)-P-Ph(2)PCH(2)P[=NP(=O)(OR)(2)]Ph(2))] (R = Et, Ph; X = Br, I, N(3), NCO (9-12a,b)). The catalytic activity of 2-8a,b in transfer hydrogenation of cyclohexanone, as well as theoretical calculations on the models [Ru(eta(6)-C(6)H(6))Cl(kappa(2)-P,N-H(2)PCH(2)P[=NP(=O)(OH)(2)]H(2))]+ and [Ru(eta(6)-C(6)H(6))Cl(kappa(2)-P,O-H(2)PCH(2)P[=NP(=O)(OH)(2)]H(2))]+, has been also studied.     

Neutral mononuclear, dinuclear, tetranuclear d7/d10 metal complexes containing bis-pyrazole/pyridine ligands supported by 2,6-bis(3-pyrazolyl)pyridine: synthesis, structure, spectra, and catalytic activity

A series of novel bis-pyrazole/pyridine complexes, [Zn(2)(HL(1))(2)(μ(2)-SO(4))](2)·EtOH·H(2)O (1), [Co(2)(HL(1))(2)(μ(2)-SO(4))](2)·2DMF·6H(2)O (2), [Zn(4)(HL(1))(4)(μ(4)-SO(4))][OH](2) (3), [Zn(2)(HL(2))(2)(μ(2)-SO(4))]·2H(2)O (4), [Zn(H(2)L(2))(H(2)O)(2)](SO(4))·0.87H(2)O (5) (H(2)L(1) = 2,6-di-(5-phenyl-1H-pyrazol-3-yl)pyridine, H(2)L(2) = 2,6-di-(5-methyl-1H-pyrazol-3-yl)pyridine), were synthesized hydrothermally from the self-assembly of Zn(II) or Co(II) with different types of bipyrazolyl/pyridine derivative ligands. All the complexes were characterized by elemental analysis, IR and UV-vis spectroscopy, powder X-ray diffraction (PXRD), and single-crystal X-ray diffraction. Structural analyses revealed that metal atoms (Zn and Co) in complexes 1-5 are five-coordination modes, forming slightly distorted trigonal bipyramidal geometries. In complexes 1-3, H(2)L(1) ligand connected the two metal centers via the tetradentate fashion, and the same form of connection was found in complex 4 with H(2)L(2) ligand. While in complex 5, H(2)L(2) only connected with one metal center via the tridentate fashion, which was different from those in complexes 1-4. Additionally, there are abundant hydrogen bonding interactions in complexes 1-4. Interestingly, for hydrogen bonding connecting fashions being different, the molecules for the complexes 1 and 4 are held together by the hydrogen bond to form a 1D supramolecular structure, whereas complexes 2 and 3 are a hydrogen bonded dimer. In addition, quantum chemical calculations for 1, 3, and 4, thermal behaviors and photoluminescent properties for 1 and 3-5 were performed and discussed in detail. In the mean time, we found that these complexes had potential catalytic activity for the oxidation reaction of cyclohexane.     

Preparation of new monoanionic "scorpionate" ligands: synthesis and structural characterization of titanium(IV) complexes bearing this class of ligand

The preparation of new "scorpionate" ligands in the form of the lithium derivatives [(Li(bdmpzdta)(H(2)O))(4)] (1) [bdmpzdta = bis(3,5-dimethylpyrazol-1-yl)dithioacetate], [Li(bdphpza)(H(2)O)(THF)] (2) [bdphpza = bis(3,5-diphenylpyrazol-1-yl)acetate], and [Li(bdphpzdta)(H(2)O)(THF)] (3) [bdphpzdta = bis(3,5-diphenylpyrazol-1-yl)dithioacetate] has been carried out. Furthermore, a series of titanium complexes has been prepared by reaction of TiCl(4)(THF)(2) with the lithium reagents [(Li(bdmpza)(H(2)O))(4)] (4) [bdmpza = bis(3,5-dimethylpyrazol-1-yl)acetate] and 1. Under the appropriate experimental conditions neutral complexes, namely [TiCl(3)(kappa(3)-bdmpza)] (5), [TiCl(3)(kappa(3)-bdmpzdta)] (6), and [TiCl(2)(kappa(2)-bdmpzdta)(2)] (7), and cationic complexes, namely [TiCl(2)(THF)(kappa(3)-bdmpza)]Cl (8) and [TiCl(2)(THF)(kappa(3)-bdmpzdta)]Cl (9), were isolated. Complexes 8 and 9 undergo an interesting nucleophilic THF ring-opening reaction to give the corresponding alkoxide-containing species [TiCl(2)(kappa(3)-bdmpza)(O(CH(2))(4)Cl)] (10) and [TiCl(2)(kappa(3)-bdmpzdta)(O(CH(2))(4)Cl)] (11). A family of alkoxide-containing complexes of general formulas [TiCl(2)(kappa(3)-bdmpza)(OR)] [R = Me (12); R = Et (14); R = (i)Pr (16); R = (t)Bu (18)] and [TiCl(2)(kappa(3)-bdmpzdta)(OR)] [R = Me (13); R = Et (15); R = (i)Pr (17)] was also prepared. The structures of these complexes have been determined by spectroscopic methods, and in addition, the X-ray crystal structures of 3, 7, 10, and 11 were also established.     

Synthesis of mononuclear and dinuclear ruthenium(II) tris(heteroleptic) complexes via photosubstitution in bis(carbonyl) precursors

A novel, and quite general, approach for the preparation of tris(heteroleptic) ruthenium(II) complexes is reported. Using this method, which is based on photosubstitution of carbonyl ligands in precursors such as [Ru(bpy)(CO)(2)Cl(2)] and [Ru(bpy)(Me(2)bpy)(CO)(2)](PF(6))(2), mononuclear and dinuclear Ru(II) tris(heteroleptic) polypyridyl complexes containing the bridging ligands 3,5-bis(pyridin-2-yl)-1,2,4-triazole (Hbpt) and 3,5-bis(pyrazin-2-yl)-1,2,4-triazole (Hbpzt) have been prepared. The complexes obtained were purified by column chromatography and characterized by HPLC, mass spectrometry, 1H NMR, absorption and emission spectroscopy and by electrochemical methods. The X-ray structures of the compounds [Ru(bpy)(Me(2)bpy)(bpt)](PF(6))x0.5C(4)H(10)O [1x0.5C(4)H(10)O], [Ru(bpy)(Me(2)bpy)(bpzt)](PF(6))xH(2)O (2xH(2)O) and [Ru(bpy)(Me(2)bpy)(CH(3)CN)(2)](PF(6))(2)xC(4)H(10)O (6xC(4)H(10)O) are reported. The synthesis and characterisation of the dinuclear analogues of 1 and 2, [{Ru(bpy)(Me(2)bpy)}(2)bpt](PF(6))(3)x2H(2)O (3) and [{Ru(bpy)(Me(2)bpy)}(2)bpzt](PF(6))(3) (4), are also described.     

Synthesis, structural, magnetic, DFT calculations and CShM studies of three new pentanuclear Mn(II) clusters

The ditopic ligand PyPzOAPz (N-[(Z)-amino(pyrazin-2-yl)methylidene]-5-methyl-1-(pyridin-2-yl)-1H-pyrazole-3-carbohydrazonic acid) was synthesized by in situ condensation of methyl imino pyrazine-2-carboxylate with 5-methyl-1-(2-pyridyl) pyrazole-3-carbohydrazide. In this work we have also used two of our earlier ligands PzCAP (5-methyl-N-[(1E)-1-(pyridin-2-yl)ethylidene]-1H-pyrazole-3-carbohydrazonic acid) (Dalton Trans., 2009, 8215) and PzOAP (N-[(Z)-amino(pyridin-2-yl)methylidene]-5-methyl-1H-pyrazole-3-carbohydrazonic acid) (Dalton Trans., 2007, 1229). These ligands PzCAP, PzOAP and PyPzOAPz were made to react with Mn(ClO(4))(2)·6H(2)O to produce three pentanuclear Mn(II) clusters [Mn(5)(PzCAP)(6)](ClO(4))(4) (1), [Mn(5)(PzOAP)(6)](ClO(4))(4) (2) and [Mn(5)(PyPzOAPz)(6)](ClO(4))(4) (3). These complexes have been characterized by X-ray structural analyses and variable temperature magnetic susceptibility measurements. All complexes have a pentanuclear core with trigonal bipyramidal arrangement of Mn(II) atoms, where, the axial metal centers have a N(3)O(3) chromophore and the equatorial centers have N(4)O(2) with an octahedral arrangement. These Mn(5)(II) clusters 1, 2 and 3 show the presence of antiferromagnetic coupling within the pentanuclear manganese(II) core (J = -2.95, -3.19 and -3.00 cm(-1) respectively). Density functional theory calculations and continuous shape measurement (CShM) studies have been performed on these complexes to provide a qualitative theoretical interpretation of the antiferromagnetic behaviour shown by them. The pentanuclear Mn(II) cluster (1) on reaction with Cu(NO(3))(2)·6H(2)O in 1:1 mole proportion in CH(3)OH:H(2)O (60?:?40) forms a homoleptic [2 × 2] tetranuclear Cu(4)(II) grid [Cu(4)(PzCAP)(4)(NO(3))(2)](NO(3))(2)·8H(2)O (4). The same Cu(4)(II) grid is also obtained from a direct reaction between the ditopic ligand PzCAP with Cu(NO(3))(2)·6H(2)O in 1:1 mole proportion. This conversion of a cluster to a grid is a novel observation.     

Synthesis of a series of 4-pyridyl-1,2,4-triazole-containing cadmium(II) luminescent complexes

Using two 4-substitued triazole ligands, 4-(pyrid-2-yl)-1,2,4-triazole (L(1)) and 4-(pyrid-3-yl)-1,2,4-triazole (L(2)), a series of novel triazole-cadmium(II) complexes varying from zero- to three-dimensional have been prepared and their crystal structures determined via single-crystal X-ray diffraction. [Cd(2)(micro(2)-L(1))(3)(L(1))(2)(NO(3))(mu(2)-NO(3))(H(2)O)(2)](NO(3))(2).1.75H(2)O (1) is a binuclear complex containing bidendate, monodedate and free nitrate anions. When the bridging anions SCN(-) and dca (dca = N(CN)(2)(-)) were added to the reaction system of 1, one-dimensional (1D) [Cd(L(1))(2)(NCS)(2)](n) (2) and two-dimensional (2D) [Cd(L(1))(2)(dca)(2)](n) (3) were isolated, respectively. When L(2) instead of L(1) was used, [Cd(L(2))(2)(NCS)(2)(H(2)O)(2)] (4) and 1D [Cd(L(2))(2)(dca)(2)](n) (5) were obtained. When the ratio of Cd to L(2) was changed from 1:2 to 1:1 in the reaction system of 5, three-dimensional (3D) {[Cd(3)(micro(2)-L(2))(3)(dca)(6)].0.75H(2)O}(n) (6) with 1D microporous channels along the a direction was isolated. Further investigations on other Cd(ii) salts and the L(2) ligand in a Cd to L(2) ratio of 1:1, an unexpected complex [Cd(mu(2)-L(2))(mu(3)-SO(4))(H(2)O)](n) (7) with a 3D open framework was obtained. All of the complexes exhibit strong blue fluorescence emission bands in the solid state at ambient temperature, of which the excitation and emission maxima are red-shifted to longer wavelength as compared to those in water. Powder X-ray diffraction and thermal studies were used to investigate the bulk nature of the 3D coordination polymers 6 and 7.     

Effect of counteranion X on the spin crossover properties of a family of diiron(II) triazole complexes [Fe(II)2(PMAT)2](X)4

Seven diiron(II) complexes, [Fe(II)(2)(PMAT)(2)](X)(4), varying only in the anion X, have been prepared, where PMAT is 4-amino-3,5-bis{[(2-pyridylmethyl)-amino]methyl}-4H-1,2,4-triazole and X = BF(4)(-) (1), Cl(-) (2), PF(6)(-) (3), SbF(6)(-) (4), CF(3)SO(3)(-) (5), B(PhF)(4)(-) (6), and C(16)H(33)SO(3)(-) (7). Most were isolated as solvates, and the microcrystalline ([3], [4]·2H(2)O, [5]·H(2)O, and [6]·?MeCN) or powder ([2]·4H(2)O, and [7]·2H(2)O) samples obtained were studied by variable-temperature magnetic susceptibility and Mo?ssbauer methods. A structure determination on a crystal of [2]·2MeOH·H(2)O, revealed it to be a [LS-HS] mixed low spin (LS)-high spin (HS) state dinuclear complex at 90 K, but fully high spin, [HS-HS], at 293 K. In contrast, structures of both [5]·?IPA·H(2)O and [7]·1.6MeOH·0.4H(2)O showed them to be [HS-HS] at 90 K, whereas magnetic and M?ssbauer studies on [5]·H(2)O and [7]·2H(2)O revealed a different spin state, [LS-HS], at 90 K, presumably because of the difference in solvation. None of these complexes undergo thermal spin crossover (SCO) to the fully LS form, [LS-LS]. The PF(6)(-) and SbF(6)(-) complexes, 3 and [4]·2H(2)O, appear to be a mixture of [HS-LS] and [HS-HS] at low temperature, and undergo gradual SCO to [HS-HS] on warming. The CF(3)SO(3)(-) complex [5]·H(2)O undergoes gradual, partial SCO from [HS-LS] to a mixture of [HS-LS] and [HS-HS] at T(1/2) ≈ 180 K. The B(PhF)(4)(-) and C(16)H(33)SO(3)(-) complexes, [6]·(1)/(2)MeCN and [7]·2H(2)O, are approximately [LS-HS] at all temperatures, with an onset of gradual SCO with T(1/2) > 300 K.     

A new [2 + 1] mixed ligand concept based on [99(m)Tc(OH2)3(CO)3]+: a basic study

Mixed ligand fac-tricarbonyl complexes of the general formula [M(L1)(L2)(CO)3](M = Re, 99(m)Tc, L1= imidazole, benzyl isocyanide, L2 = 1H-imidazole-4-carboxylic acid, pyridine-2,4-dicarboxylic acid, pyridine-2,5-dicarboxylic acid) have been prepared starting from the precursors [M(OH2)3(CO)3]+. The complexes can be obtained in good yield and purity in a two-step procedure by first attaching the bidentate ligand followed by addition of the monodentate. 99mTc compounds can also be prepared at the tracer level in one-pot procedures with L1 and L2 being concomitantly present. This [2 + 1] approach allows the labeling of bioactive molecules containing a monodentate or a bidentate donor site. Examples given in here are N-(tert-butoxycarbonyl)glycyl-N-(3-(imidazol-1-yl)propyl)phenylalaninamide, 5-((3-(imidazol-1-yl)propyl)aminomethyl)-2'-deoxyuridine and 4-(5-isonitrilpentyl)-1-(2-methoxyphenyl)-piperazine as L1 and N-((6-carboxypyridine-3-yl)methyl)glycylphenylalanine as L2. The corresponding second ligand can be used to influence the physico-chemical properties of the conjugate. The crystal structures of [99Tc(OH2)(imc)(CO)3], [Re(OH2)(2,4-dipic)(CO)3], [Re(bic)(2,4-dipic)(CO)3] and [Re(im)(2,5-dipic)(CO)3] are reported.     

Synthesis and antimicrobial activity of N-(substituted)-N'-(2,3-dihydro-2-oxido-5-benzoyl-1H-1,3,2-benzodiazaphosphol-2-yl) ureas

N-(substituted)-N'-(2,3-dihydro-5-benzoyl-2-oxido-1H-1,3,2-benzodiazaphosphol-2-yl) ureas were synthesized by reacting 3,4-diaminobenzophenone (4) with different chlorides of carbamidophosphoric acids (3) in the presence of triethylamine at 40-45 degrees C. Their 1H-, 13C- and 31P-NMR spectral data are discussed. The title compounds were screened for antifungal and antibacterial activity against the fungi Aspergillus niger and Fusarium solani and bacteria Escherichia coli and Staphylococcus aureus. These compounds showed higher antibacterial activity when compared with antifungal activity.     

New complexes of zirconium(IV) and hafnium(IV) with heteroscorpionate ligands and the hydrolysis of such complexes to give a zirconium cluster

A series of zirconium and hafnium heteroscorpionate complexes have been prepared by the reaction of MCl4 (M = Zr, Hf) with the compounds [[Li(bdmpza)(H2O)](4)] [bdmpza = bis(3,5-dimethylpyrazol-1-yl)acetate], [[Li(bdmpzdta)(H2O)](4)] [bdmpzdta = bis(3,5-dimethylpyrazol-1-yl)dithioacetate], and (Hbdmpze) [bdmpze = 2,2-bis(3,5-dimethylpyrazol-1-yl)ethoxide] (the latter with the prior addition of Bu(n)Li). Under the appropriate experimental conditions, mononuclear complexes, namely, [MCl3(kappa3-bdmpzx)] [x = a, M = Zr (1), Hf (2); x = dta, M = Zr (3), Hf (4); x = e, M = Zr (5), Hf (6)], and dinuclear complexes, namely, [[MCl2(mu-OH)(kappa3-bdmpzx)]2] [x = a, M = Zr (7), Hf (8); x = dta, M = Zr (9); x = e, M = Zr (10)], were isolated. A family of alkoxide-containing complexes of the general formula [ZrCl2(kappa3-bdmpzx)(OR)] [x = a, R = Me (11), Et (12), iPr (13), tBu (14); x = dta, R = Me (15), Et (16), iPr (17), tBu (18); x = e, R = Me (19), Et (20), (i)Pr (21), (t)Bu (22)] was also prepared. Complexes 11-14 underwent an interesting hydrolysis process to give the cluster complex [Zr6(mu3-OH)8(OH)8(kappa2-bdmpza)8] (23). The structures of these complexes have been determined by spectroscopic methods, and the X-ray crystal structures of 7, 8, and 23 were also established.     

Unexpected metal-induced isomerisms and phosphoryl migrations in Pt(II) and Pd(II) complexes of the functional phosphine 2-(bis(diphenylphosphino)methyl)-oxazoline

The reaction of the functional diphosphine 1 [1 = 2-(bis(diphenylphosphino)methyl-oxazoline] with [PtCl(2)(NCPh)(2)] or [PdCl(2)(NCPh)(2)], in the presence of excess NEt(3), affords [Pt{(Ph(2)P)(2)C···C(···NCH(2)CH(2)O)}(2)] ([Pt(1(-H)-P,P)(2)], 3a) and [Pd{(Ph(2)P)(2)C···C(···NCH(2)CH(2)O)}(2)] ([Pd(1(-H)-P,P)(2)], 3b), respectively, in which 1(-H) is (oxazoline-2-yl)bis(diphenylphosphino)methanide. The reaction of 3b with 2 equiv of [AuCl(tht)] (tht = tetrahydrothiophene) afforded [Pd(1(-H)-P,N)(2)(AuCl)(2)] (4), as a result of the opening of the four-membered metal chelate since ligand 1(-H), which was P,P-chelating in 3b, behaves as a P,N-chelate toward the Pd(II) center in 4 and coordinates to Au(I) through the other P donor. In the absence of a base, the reaction of ligand 1 with [PtCl(2)(NCPh)(2)] in MeCN or CH(2)Cl(2) afforded the isomers [Pt{(Ph(2)P)(2)C═C(OCH(2)CH(2)NH)}(2)]Cl(2) ([Pt(1'-P,P)(2)]Cl(2) (5), 1' = 2-(bis(diphenylphosphino)methylene)-oxazolidine) and [Pt{(Ph(2)P)(2)C═C(OCH(2)CH(2)NH)}{Ph(2)PCH═C(OCH(2)CH(2)N(PPh(2))}]Cl(2) ([Pt(1'-P,P)(2'-P,P)]Cl(2) (6), 2' = (E)-3-(diphenylphosphino)-2-((diphenylphosphino)methylene)oxazolidine]. The P,P-chelating ligands in 5 result from a tautomeric shift of the C-H proton of 1 to the nitrogen atom, whereas the formation of one of the P,P-chelates in 6 involves a carbon to nitrogen phosphoryl migration. The reaction of 5 and 6 with a base occurred by deprotonation at the nitrogen to afford 3a and [Pt{(Ph(2)P)(2)C···C(···NCH(2)CH(2)O)}{Ph(2)PCH═COCH(2)CH(2)N(PPh(2))}]Cl ([Pt(1(-H)-P,P)(2'-P,P)]Cl (7)], respectively. In CH(2)Cl(2), an isomer of 3a, [Pt{Ph(2)P)(2)C···C(···NCH(2)CH(2)O)}{Ph(2)PC(PPh(2))═COCH(2)CH(2)N}] ([Pt(1(-H)-P,P)(1(-H)-P,N)] (8)), was obtained as a side product which contains ligand 1(-H) in two different coordination modes. Complexes 3b·4CH(2)Cl(2), 4·CHCl(3), 6·2.5CH(2)Cl(2), and 8·CH(2)Cl(2) have been structurally characterized by X-ray diffraction.     

Ruthenium(II) complexes containing bis(2-(diphenylphosphino)phenyl) ether and their catalytic activity in hydrogenation reactions

The half-sandwich complexes [(eta5-C5H5)RuCl(DPEphos)] (1) and [{(eta6-p-cymene)RuCl2}2(mu-DPEphos)] (2) were synthesized by the reaction of bis(2-(diphenylphosphino)phenyl) ether (DPEphos) with a mixture of ruthenium trichloride trihydrate and cyclopentadiene and with [(eta6-p-cymene)RuCl2]2, respectively. Treatment of DPEphos with cis-[RuCl2(dmso)4] afforded fac-[RuCl2(kappa3-P,O,P-DPEphos)(dmso)] (3). The dmso ligand in 3 can be substituted by pyridine, 2,2'-bipyridine, 4,4'-bipyridine, and PPh3 to yield trans,cis-[RuCl2(DPEphos)(C5H5N)2] (4), cis,cis-[RuCl2(DPEphos)(2,2'-bipyridine)] (5), trans,cis-[RuCl2(DPEphos)(mu-4,4'-bipyridine)]n (6), and mer,trans-[RuCl2(kappa3-P,P,O-DPEphos)(PPh3)] (7), respectively. Refluxing [(eta6-p-cymene)RuCl2]2 with DPEphos in moist acetonitrile leads to the elimination of the p-cymene group and the formation of the octahedral complex cis,cis-[RuCl2(DPEphos)(H2O)(CH3CN)] (8). The structures of the complexes 1-5, 7, and 8 are confirmed by X-ray crystallography. The catalytic activity of these complexes for the hydrogenation of styrene is studied.     

Dinuclear copper(II) complexes with {Cu2(mu-hydroxo)bis(mu-carboxylato)}+ cores and their reactions with sugar phosphate esters: A substrate binding model of fructose-1,6-bisphosphatase

Reactions of CuX2.nH2O with the biscarboxylate ligand XDK (H2XDK = m-xylenediamine bis(Kemp's triacid imide)) in the presence of N-donor auxiliary ligands yielded a series of dicopper(II) complexes, [Cu2(mu-OH)(XDK)(L)2]X (L = N,N,N',N'-tetramethylethylenediamine (tetmen), X = NO3 (1a), Cl (1b); L = N,N,N'-trimethylethylenediamine (tmen), X = NO3 (2a), Cl (2b); L =2,2'-bipyridine (bpy), X = NO3 (3); L = 1,10-phenanthroline (phen), X = NO3 (4); L = 4,4'-dimethyl-2,2'-bipyridine (Me2bpy), X = NO3 (5); L = 4-methyl-1,10-phenanthroline (Mephen), X = NO3 (6)). Complexes 1-6 were characterized by X-ray crystallography (Cu...Cu = 3.1624(6)-3.2910(4) A), and the electrochemical and magnetic properties were also examined. Complexes 3 and 4 readily reacted with diphenyl phosphoric acid (HDPP) or bis(4-nitrophenyl) phosphoric acid (HBNPP) to give [Cu2(mu-phosphate)(XDK)(L)2]NO3 (L = bpy, phosphate = DPP (11); L = phen, phosphate = DPP (12), BNPP (13)), where the phsophate diester bridges the two copper ions in a mu-1,3-O,O' bidentate fashion (Cu...Cu = 4.268(3)-4.315(1) A). Complexes 4 and 6 with phen and Mephen have proven to be good precursors to accommodate a series of sugar monophosphate esters (Sugar-P) onto the biscarboxylate-bridged dicopper centers, yielding [Cu2(mu-Sugar-P)(XDK)(L)2] (Sugar-P = alpha-D-Glc-1-P (23a and b), D-Glc-6-P (24a and b), D-Man-6-P (25a), D-Fru-6-P (26a and b); L = phen (a), Mephen (b)) and [Cu2(mu-Gly-n-P)(XDK)(Mephen)2] (Gly-n-P = glycerol n-phosphate; n = 2 (21), 3 (22)), where Glc, Man, and Fru are glucose, mannose, and fructose, respectively. The structure of [Cu2(mu-MNPP)(XDK)(phen)2(CH3OH)] (20) was characterized as a reference compound (H2MNPP = 4-nitrophenyl phosphoric acid). Complexes 4 and 6 also reacted with d-fructose 1,6-bisphosphate (D-Fru-1,6-P2) to afford the tetranuclear copper(II) complexes formulated as [Cu4(mu-D-Fru-1,6-P2)(XDK)2(L)4] (L = phen (27a), Mephen (27b)). The detailed structure of 27a was determined by X-ray crystallography to involve two different tetranuclear complexes with alpha- and beta-anomers of D-Fru-1,6-P2, [Cu4(mu-alpha-D-Fru-1,6-P2)(XDK)2(phen)4] and [Cu4(mu-beta-D-Fru-1,6-P2)(XDK)2(phen)4], in which the D-Fru-1,6-P2 tetravalent anion bridges the two [Cu2(XDK)(phen)2]2+ units through the C1 and C6 phosphate groups in a mu-1,3-O,O' bidentate fashion (Cu...Cu = 4.042(2)-4.100(2) A). Notably, the structure with alpha-D-Fru-1,6-P2 demonstrated the presence of a strong hydrogen bond between the C2 hydroxyl group and the C1 phosphate oxygen atom, which may support the previously proposed catalytic mechanism in the active site of fructose-1,6-bisphosphatase.     

Electrochemical synthesis and structural characterization of silver(I) complexes of N-2-pyridyl sulfonamide ligands with different nuclearity: influence of the steric hindrance at the pyridine ring and the sulfonamide group on the structure of the complexes

A new series of silver complexes, [AgL], of the anionic forms of potentially bidentate N-2-pyridyl sulfonamide ligands [N-(3-methyl-2-pyridyl)-p-toluenenesulfonamide (HTs3mepy), N-(3-methyl-2-pyridyl)mesitylenesulfonamide (HMs3mepy), N-(4-methyl-2-pyridyl)-p-toluenesulfonamide (HTs4mepy), and N-(6-methyl-2-pyridyl)mesitylenesulfonamide (HMs6mepy)] have been prepared by an electrochemical procedure. In addition, heteroleptic complexes of composition [AgLL'] (L' = 1,10-phenanthroline and 2,2'-bipyridine) were obtained when the coligand L' was added to the electrolytic phase. The complexes were characterized by microanalysis, IR and (1)H NMR spectroscopy, and LSI mass spectrometry. In the cases of the compounds [Ag(Ts3mepy)](n)() (1), [Ag(4)(Ms3mepy)(4)] (2a), [Ag(Ms3mepy)](n)() (2b), [Ag(4)(Ms6mepy)(4)] (3a), [Ag(2)(Ms6mepy)(2)](n)() (3b), [Ag(2)(Ms3mepy)(2)(phen)(2)] (5), [Ag(2)(Ms6mepy)(2)phen] (7), and [Ag(2)(Ts4mepy)(2)(bipy)(2)] (8), characterization was also carried out by single-crystal X-ray diffraction. Compounds 1 and 2b present a polymer structure formed by an {AgN(2)} digonal core. Compounds 2a and 3a are tetranuclear and also have a distorted {AgN(2)} digonal core. Compound 3b is based on binuclear distorted {AgN(2)} digonal units joined by an intermolecular sulfonyl oxygen atom to produce a stairlike polymer structure. The heteroleptic complexes 5 and 8 are dimeric with a distorted {AgN(4)} tetrahedral geometry, while compound 7 shows two different geometries around the metal, distorted {AgN(2)} digonal and {AgN(4)} tetrahedral. The supramolecular structures of all species are organized by pi,pi-stacking, C-H...pi, or C-H...O interactions.     

Reactions of [(eta(6)-arene)RuCl(2)](2) with Aromatic Phosphines Containing Methoxy Groups in 2,6-Positions

Reactions of [(eta(6)-arene)RuCl(2)](2) 1 (arene = p-cymene (a), 1,2,3,4-Me(4)C(6)H(2) (b), 1,2,3-Me(3)C(6)H(2) (c)) with tris(2,6-dimethoxyphenyl)phosphine (TDMPP) led to loss of two molecules of CH(3)Cl to give (eta(6)-arene)Ru[{2-O-C(6)H(3)-6-OMe}(2){C(6)H(3)(OMe)(2)-2,6}], 2a-c, which contains a trihapto ligand (eta(3)-P,O,O) derived from TDMPP, whereas the 1,3,5-Me(3)C(6)H(3) (1d), 1,2,3,5-Me(4)C(6)H(2) (1e), and C(6)Me(6) (1f) complexes did not react with TDMPP. The structures of 2a and 2b were confirmed by X-ray analyses: for 2a, a = 11.691(2) ?, b = 15.228(2) ?, c = 10.320(1) ?, alpha = 95.93(1) degrees, beta = 113.783(9) degrees, gamma = 83.86(1) degrees, triclinic, P&onemacr;, Z = 2, R = 0.051; for 2b, a = 17.79(2) ?, b = 15.43(1) ?, c = 20.93(1) ?, beta = 91.25(8) degrees, monoclinic, P2(1)/n, Z = 8, R = 0.056. Bis(2,6-dimethoxyphenyl)phenylphosphine (BDMPP) reacted with 1a, 1b, and 1d at room temperature to give (eta(6)-arene)RuCl[PPh(2-O-C(6)H(3)-6-OMe){C(6)H(3)(OMe)(2)-2,6}], 3a,b,d, which contains a dihapto (eta(2)-P,O) ligand derived from BDMPP by an X-ray analysis of 3a: a = 12.33(1) ?, b = 14.246(8) ?, c = 11.236(9) ?, alpha = 91.47(8) degrees, beta = 117.28(6) degrees, gamma = 111.70(6) degrees, triclinic, P&onemacr;, Z = 2, R = 0.040. A similar reaction with 1f recovered the starting materials, but that in refluxing MeCN produced [(eta(6)-C(6)Me(6))Ru[PPh(2-O-C(6)H(3)-6-OMe}(2)], 4f, containing a trihapto (eta(3)-P,O,O) ligand derived from BDMPP. Complex 1d reacted with BDMPP at reflux in MeCN/CH(2)Cl(2) and resulted in a loss of an arene ring to give a five-coordinate complex, Ru[eta(2)-P,O-PPh(2-O-C(6)H(3)-6-OMe){C(6)H(3)(OMe)(2)-2,6}](2)(MeCN), 5. Treatment of (2,6-dimethoxyphenyl)diphenylphosphine (MDMPP) with 1f gave (eta(6)-C(6)Me(6))RuCl[eta(2)-P,O-PPh(2)(2-O-C(6)H(3)-6-OMe)],6f, and that with 1b gave (eta(6)-1,2,3,4-Me(4)C(6)H(2))RuCl[eta(2)-P,O-PPh(2)(2-O-C(6)H(3)-6-OMe}], 6b, and (eta(6)-1,2,3,4-Me(4)C(6)H(2))RuCl(2)[eta(1)-P-PPh(2){C(6)H(3)(OMe)(2)-2,6}],7b. The phosphine ligand of 6b acted as a bidentate ligand derived from MDMPP: a = 8.074(4) ?, b = 16.816(3) ?, c = 18.916(4) ?, beta = 94.05(3) degrees, monoclinic, P2(1)/n, Z = 4, R = 0.051. Transformation of 7b to 6b readily occurred accompanying an elimination of MeCl. Reaction of 1a with MDMPP eliminated an arene ring to give the octahedral compound RuCl(2)[eta(2)-P,OMe-PPh(2){C(6)H(3)(MeO)(2)-2,6}](2), 8. An X-ray analysis of 8 showed that two MDMPP ligands were in a cis-position: a = 10.596(14) ?, b = 27.586(12) ?, c = 13.036(8) ?, beta = 108.17(7) degrees, monoclinic, P2(1)/n, Z = 4, R = 0.035.     

Probing stepwise reaction of NNP-ligand copper(I) complex with elemental sulfur by using N-heterocyclic carbene as a trapper

The dinuclear NNP-ligand copper(I) complex [o-N═CH(C(4)H(3)N)-PPh(2)C(6)H(4)](2)Cu(2) (1) has been synthesized by the reaction of (CuMes)(4) (Mes = 2,4,6-Me(3)C(6)H(2)) with N-((1H-pyrrol-2-yl)-methylene)-2-(diphenylphosphino)benzenamine under an elimination of MesH. Further reaction of 1 with an excess of S(8) produced a mononuclear Cu(II) complex [o-N═CH(C(4)H(3)N)-P(S)Ph(2)C(6)H(4)](2)Cu (5) and CuS. CuS was identified by Raman spectroscopy and 1 and 5 were clearly confirmed by X-ray crystallography. The N-heterocyclic carbene was employed to react with 1 to give a mononuclear [o-N═CH(C(4)H(3)N)-PPh(2)C(6)H(4)]Cu{C[N(iPr)CMe](2)} (2). The reactions of 2 were carried out with (1)/(8), (2)/(8), and (5)/(8) equiv of S(8), leading to compounds [o-N═CH(C(4)H(3)N)-P(S)Ph(2)C(6)H(4)]Cu{C[N(iPr)CMe](2)} (3), [o-N═CH(C(4)H(3)N)-P(S)Ph(2)C(6)H(4)]Cu (4), and 5 respectively, in which CuS was generated in the third reaction and S═C[N(iPr)CMe](2) in the latter two reactions. The clean confirmation of 2-4 demonstrates a stepwise reaction process of 1 with S(8) to 5 and CuS and the N-heterocyclic carbene acts well as a trapping agent.     

Binuclear copper(II) complexes of xylyl-bridged bis(1,4,7-triazacyclononane) ligands

Copper(II) complexes of three bis(tacn) ligands, [Cu(2)(T(2)-o-X)Cl(4)] (1), [Cu(2)(T(2)-m-X)(H(2)O)(4)](ClO(4))(4).H(2)O.NaClO(4) (2), and [Cu(2)(T(2)-p-X)Cl(4)] (3), were prepared by reacting a Cu(II) salt and L.6HCl (2:1 ratio) in neutral aqueous solution [T(2)-o-X = 1,2-bis(1,4,7-triazacyclonon-1-ylmethyl)benzene; T(2)-m-X = 1,3-bis(1,4,7-triazacyclonon-1-ylmethyl)benzene; T(2)-p-X = 1,4-bis(1,4,7-triazacyclonon-1-ylmethyl)benzene]. Crystals of [Cu(2)(T(2)-m-X)(NPP)(mu-OH)](ClO(4)).H(2)O (4) formed at pH = 7.4 in a solution containing 2 and disodium 4-nitrophenyl phosphate (Na(2)NPP). The binuclear complexes [Cu(2)(T(2)-o-XAc(2))(H(2)O)(2)](ClO(4))(2).4H(2)O (5) and [Cu(2)(T(2)-m-XAc(2))(H(2)O)(2)](ClO(4))(2).4H(2)O (6) were obtained on addition of Cu(ClO(4))(2).6H(2)O to aqueous solutions of the bis(tetradentate) ligands T(2)-o-XAc(2) (1,2-bis((4-(carboxymethyl)-1,4,7-triazacyclonon-1-yl)methyl)benzene and T(2)-m-XAc(2) (1,3-bis((4-(carboxymethyl)-1,4,7-triazacyclonon-1-yl)methyl)benzene), respectively. In the binuclear complex, 3, three N donors from one macrocycle and two chlorides occupy the distorted square pyramidal Cu(II) coordination sphere. The complex features a long Cu...Cu separation (11.81 A) and intermolecular interactions that give rise to weak intermolecular antiferromagnetic coupling between Cu(II) centers. Complex 4 contains binuclear cations with a single hydroxo and p-nitrophenyl phosphate bridging two Cu(II) centers (Cu...Cu = 3.565(2) A). Magnetic susceptibility studies indicated the presence of strong antiferromagnetic interactions between the metal centers (J = -275 cm(-1)). Measurements of the rate of BNPP (bis(p-nitrophenyl) phosphate) hydrolysis by a number of these metal complexes revealed the greatest rate of cleavage for [Cu(2)(T(2)-o-X)(OH(2))(4)](4+) (k = 5 x 10(-6) s(-1) at pH = 7.4 and T = 50 degrees C). Notably, the mononuclear [Cu(Me(3)tacn)(OH(2))(2)](2+) complex induces a much faster rate of cleavage (k = 6 x 10(-5) s(-1) under the same conditions).     

Synthesis and crystal structure of complex of Ce(NO_3)_3 with N-(3-methyl-pyridin-2-yl)-formimidoyl-(3-methyl-pyridin-2-yl) hydrazone

Rare earth complexes with organic ligands have been used as luminescence-material usually. Except their luminescent property, the complexes of trivalent lanthanide ions have low toxicity and powerful para-magnetic properties[1,2], so the lanthanide complexes are associated with important biological uses as diag-nostic tools and medicines[36]. Recently, there are some reports on Ce(III) complexes, some of which show anti-cancer activities[7]. S- tetrazines can be used as poly-dentate chelatin…